CENTAD Conference on Compulsory Licensing and Access to Patented Knowledge

One-Day Preliminary National Consultation on Access to Patented Knowledge Organized by: Centre for Trade and Development (Centad), New Delhi Topic: “Patents and Platform Technologies: Understanding Implications for Research and Development in Malaria and Tuberculosis” Date: 9th September 2009 (Wednesday) Venue: Magnoria Hall, India Habitat Centre, New Delhi The International Development Research Centre (IDRC), Canada, commissioned a study to Centre for Trade and Development (Centad) in the area of access to patented knowledge. Centad is among the six worldwide research based […]

CENTAD Conference on Compulsory Licensing and Access to Patented Knowledge Read More »

Mashelkar vs Correa: Is a Malaysian NGO Taking the Business Standard for a Ride?

Pursuant to our earlier post calling for the dumping of a trashy editorial by the Business Standard, we’ve received an anonymous comment to our post as below: “Certain prominent peoples working in a malaysia baseda and Delhi based NGO is behind the wrongful interpretation of carlos correa report. the author of the report in the Business Standard is neither a lawyer who can interpret or a patent expert. there are few people working in a delhi based and malaysia based

Mashelkar vs Correa: Is a Malaysian NGO Taking the Business Standard for a Ride? Read More »

The Correa Controversy: Clarifying Popular "Mashelkar Myths"

Pursuant to our last post highlighting the rather trashy editorial by the Business Standard, here is an email exchange I’ve had with a friend. I am posting this here, only because it appears that that there is still some confusion about the mandate of the Committee. And some very popular “Mashelkar Myths” continue to do the rounds. For our previous posts on this controversy, please see here, here and here. And for those of you who wish to read all

The Correa Controversy: Clarifying Popular "Mashelkar Myths" Read More »

The "Correa" Controversy: Dump Mashelkar or Dump the Business Standard?

After the rather curious note in the Business Standard suggesting that Professor Correa is miffed over the apparent “mis-quote” of his statements by the Mashelkar Committee in their revised report, the Business Standard (BS) now carries a terribly misguided editorial. I’m not sure if this editorial was motivated by forces that wish to engage in a further character assassination of Dr Mashelkar and bring him down at any cost…however, what is obvious is that this editorial represents a real “low”

The "Correa" Controversy: Dump Mashelkar or Dump the Business Standard? Read More »

Delhi HC refuses to let ‘patent linkage’ in through the back door

The Delhi High Court on the 18th of this month in a judgment delivered by Justice Ravindra Bhat dismissing a writ petition filed by Bayer Corporation. Bayer Corporation sought to restrain the grant of a license under the Drugs and Cosmetics Act (henceforth referred to as Drugs Act) to Cipla for its drug “Soranib”. The landmark judgment also awarded costs amounting to Rs 6,75,000 which is payable in equal shares to the Union of India and Cipla. (There has been

Delhi HC refuses to let ‘patent linkage’ in through the back door Read More »

National Law School of India Review: Call for Papers

The National Law School of India Review has issued a call for papers for publication in Volume 22(1). Here is the call: The National Law School of India Review (NLSIR) is the flagship journal of one of India’s premier law institutions, the National Law School of India University, Bangalore. The NLSIR is a peer-reviewed journal, and is published twice a year. The latest issue – Volume 21(1) – included contributions from Justice S.B. Sinha, Judge, Supreme Court of India; Mr.

National Law School of India Review: Call for Papers Read More »

Mashelkar Committee on Patents and Prof Correa: Court(quote)ing a New Controversy?

A very curious article popped up in the Business Standard (BS) yesterday. Apparently, Prof Carlos Correa is miffed that the Technical Expert Group (TEG, headed by Dr Mashelkar) has misquoted him. I’ve combed through Correa’s article and the revised report by the Masehelkar Committee and can’t exactly fathom as to how Correa claims to have been misquoted. The record would suggest that the expert committee rightly (and contextually) cited Prof Correa. This is what the BS stated: “Patent expert says

Mashelkar Committee on Patents and Prof Correa: Court(quote)ing a New Controversy? Read More »

NUJS IP Talk: Raj Gandesha on Section 3(d) and Incremental Innovation

Raj Gandesha, a patent litigation attorney with White and Case, New York, will visit NUJS on the 25th of this month (coming Tuesday) and speak on “Pharmaceutical Innovations: A 3-D Perspective”. The event will be held in Room 006 of NUJS, starting at 4 pm and expecting to finish at 6 pm. In particular, Raj will discuss a report that he authored on behalf of the US India Business Council (USIBC) on this theme. This report has proved controversial owing

NUJS IP Talk: Raj Gandesha on Section 3(d) and Incremental Innovation Read More »

Indian "Bayh Dole" Conference at NUJS in September

Details of a Conference that the IP Chair at NUJS (along with IPTLS and Share) is organising on the 12th of September at the NUJS Auditorium, Salt Lake Kolkata. Registration is free. However, if you wish to attend, please email Prakruthi Gowda ([email protected]) indicating your name, designation etc. Publicly Funded Patents and Technology Transfer: A Review of the Indian “Bayh Dole” Bill In January 2009, the government introduced the Protection and Utilisation of Public Funded Intellectual Property Bill, 2008 in

Indian "Bayh Dole" Conference at NUJS in September Read More »

Scroll to Top